+ New Watchlist

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Aptose Biosciences

APTONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$0.390925

0.012.74%

At close: -

$0.388800

-0.0021-0.54%

After Hours: 6:44 PM EDT

Q3 2024 Earnings were released on Fri Nov 8th, after the market close

Aptose Biosciences (APTO) Forecast

News

Earnings Aptose Biosciences (APTO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Aptose Biosciences (NASDAQ:APTO) Stock

Aptose Biosciences Stock (NASDAQ: APTO)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, November 08, 2024

Aptose Biosciences Q3 2024 GAAP EPS $(0.37) B...
Benzinga Newsdesk

Tuesday, September 03, 2024

Aptose shares are trading higher after the co...
Benzinga Newsdesk
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Hello Group, Zscaler And 3 Stocks To Watch Heading Into Tuesday
Avi Kapoor

Friday, August 30, 2024

Aptose shares are trading higher after the co...
Benzinga Newsdesk
Aptose Biosciences Secures $10M Loan From Han...
Benzinga Newsdesk

Thursday, August 08, 2024

Aptose Biosciences Q2 2024 GAAP EPS $(0.43) B...
Benzinga Newsdesk

Friday, June 14, 2024

HC Wainwright & Co. Reiterates Buy on Aptose ...
Benzinga Newsdesk
Aptose Showcases Clinical And Preclinical Res...
Benzinga Newsdesk

Thursday, June 13, 2024

Aptose Biosciences Shares Move Higher; Trader...
Benzinga Newsdesk

Friday, May 31, 2024

Aptose Announces $4.43M Registered Direct Off...
Benzinga Newsdesk

Thursday, May 16, 2024

Canaccord Genuity Maintains Buy on Aptose Bio...
Benzinga Newsdesk

Tuesday, May 14, 2024

Aptose Biosciences Q1 EPS $(0.73) Beats $(0.7...
Benzinga Newsdesk

Wednesday, April 03, 2024

Piper Sandler Maintains Overweight on Aptose ...
Benzinga Newsdesk

Wednesday, March 27, 2024

HC Wainwright & Co. Maintains Buy on Aptose B...
Benzinga Newsdesk

Tuesday, March 26, 2024

Aptose Biosciences Q4 EPS $(1.44) Beats $(1.5...
Benzinga Newsdesk
Recap: Aptose Biosciences Q4 Earnings
Benzinga Insights
Aptose Reports FY23 Loss Per Share Of $(7.58)...
Benzinga Newsdesk
Earnings Scheduled For March 26, 2024
Benzinga Insights

Monday, March 25, 2024

Aptose Biosciences's Earnings: A Preview
Benzinga Insights

Thursday, February 01, 2024

Piper Sandler Maintains Overweight on Aptose ...
Benzinga Newsdesk

Friday, January 26, 2024

Aptose Announces Pricing Of Underwritten Offe...
Benzinga Newsdesk
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Avi Kapoor

Sunday, December 10, 2023

Aptose Tuspetinib Clinical Data Featured In Oral Presentation Saturday At 2023 ASH Meeting; Said TUS/VEN Combination Active Across Broad Populations Of AML And Demonstrates 25% Complete Response Rate Among All-comers, Including 20% CRc In Wildtype AML
Charles Gross

Monday, December 04, 2023

Aptose Biosciences Files For Offering 4.1M Co...
Benzinga Newsdesk

Friday, November 10, 2023

RBC Capital Maintains Outperform on Aptose Bi...
Benzinga Newsdesk

Thursday, November 09, 2023

Aptose Biosciences: Q3 Earnings Insights
Benzinga Insights
Aptose Biosciences Q3 EPS $(1.76) Beats $(2.0...
Benzinga Newsdesk
Earnings Scheduled For November 9, 2023
Benzinga Insights

Thursday, November 02, 2023

Aptose Tuspetinib Clinical Data Selected For ...
Benzinga Newsdesk

Monday, October 30, 2023

Why ON Semiconductor Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Lisa Levin

Monday, October 16, 2023

Aptose Biosciences shares are trading higher ...
Benzinga Newsdesk
Aptose Biosciences Announced That Two Abstrac...
Benzinga Newsdesk

Tuesday, October 03, 2023

Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights

Thursday, September 07, 2023

Expert Ratings for Aptose Biosciences
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on Ap...
Benzinga Newsdesk

Friday, August 11, 2023

Piper Sandler Maintains Overweight on Aptose ...
Benzinga Newsdesk
RBC Capital Maintains Outperform Rating for Aptose Biosciences: Here's What You Need To Know
Benzinga Insights
RBC Capital Maintains Outperform on Aptose Bi...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Aptose B...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Aptose Bi...
Benzinga Newsdesk

Thursday, August 10, 2023

Aptose Biosciences Q2 EPS $(2.27) Misses $(2....
Benzinga Newsdesk
Earnings Scheduled For August 10, 2023
Benzinga Insights

Wednesday, July 26, 2023

Stocks That Hit 52-Week Lows On Wednesday
Benzinga Insights

Monday, June 26, 2023

Aptose Biosciences Meets Nasdaq Minimum Bid P...
Benzinga Newsdesk

Tuesday, June 20, 2023

Aptose Biosciences Filed For Resale Of Up To ...
Charles Gross

Monday, June 12, 2023

Aptose Biosciences shares are trading higher ...
Benzinga Newsdesk
Cantor Fitzgerald Maintains Overweight on Apt...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Aptose B...
Benzinga Newsdesk
Oppenheimer Maintains Outperform on Aptose Bi...
Benzinga Newsdesk

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved